Published studies have consistently reported that elevated STMN1 expression is associated with poorer survival in various cancers, including head and neck squamous cell carcinoma, gallbladder carcinoma, esophageal squamous cell carcinoma, breast cancer, and endometrial carcinoma. Here, STMN1 is linked to breast cancer.